Upcoming Login Downtime

We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.

For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
ARTICLE | Management Tracks

Moeller named CEO of BenevolentAI

Plus: new CFO at Orion and updates from Alkeus and Immorta

January 25, 2024 12:01 AM UTC

BenevolentAI S.A. (Euronext:BAI) named Joerg Moeller as CEO and appointed him to the company’s board. Moeller succeeds acting CEO François Nader, who will return to the role of independent non-executive chair. Moeller was previously EVP, head of global R&D at Leo Pharma A/S.

Orion Corp. (HSE:ORNAV; HSE:ORNBV) hired René Lindell as CFO, effective May 1. Lindell, who will join the Finnish pharma as executive adviser in April, was CFO at Rovio Entertainment Corp. He succeeds CFO Jari Karlson, who will retire on April 30. ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article